PT932613E - Expressao de bloqueio de factoes de virulencia em s. aureus - Google Patents

Expressao de bloqueio de factoes de virulencia em s. aureus

Info

Publication number
PT932613E
PT932613E PT97927727T PT97927727T PT932613E PT 932613 E PT932613 E PT 932613E PT 97927727 T PT97927727 T PT 97927727T PT 97927727 T PT97927727 T PT 97927727T PT 932613 E PT932613 E PT 932613E
Authority
PT
Portugal
Prior art keywords
aureus
expression
virulence
facts
blocking
Prior art date
Application number
PT97927727T
Other languages
English (en)
Inventor
Richard P Novick
Ji Guangyong
Beavis Ronald
Original Assignee
Univ New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York filed Critical Univ New York
Publication of PT932613E publication Critical patent/PT932613E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of Combustion (AREA)
  • Air Conditioning Control Device (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Heat Treatment Of Steel (AREA)
  • Electrotherapy Devices (AREA)
PT97927727T 1996-05-22 1997-05-22 Expressao de bloqueio de factoes de virulencia em s. aureus PT932613E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65122696A 1996-05-22 1996-05-22

Publications (1)

Publication Number Publication Date
PT932613E true PT932613E (pt) 2005-06-30

Family

ID=24612055

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97927727T PT932613E (pt) 1996-05-22 1997-05-22 Expressao de bloqueio de factoes de virulencia em s. aureus

Country Status (8)

Country Link
EP (1) EP0932613B1 (pt)
JP (1) JP2000511537A (pt)
AT (1) ATE290548T1 (pt)
AU (1) AU735283B2 (pt)
CA (1) CA2256465A1 (pt)
DE (1) DE69732709T2 (pt)
PT (1) PT932613E (pt)
WO (1) WO1997044349A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724859D0 (en) * 1997-11-26 1998-01-21 Univ Nottingham Compounds and their use as antibacterial agents
US7323179B2 (en) 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US7534857B2 (en) 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
US6337385B1 (en) 1998-06-24 2002-01-08 The Rockefeller University Staphylococcus peptides for bacterial interference
CA2331888A1 (en) * 1998-06-24 1999-12-29 The Rockefeller University Novel staphylococcus peptides for bacterial interference
EP1862549A3 (en) 1998-09-15 2008-02-13 Naomi Balaban Target of RNAIII activating protein (TRAP)
US6747129B1 (en) 1998-09-15 2004-06-08 The Regents Of The University Of California Target of RNAIII activating protein(TRAP)
EP1188831B1 (en) * 1998-09-15 2007-12-05 Naomi Balaban Target of RNAIII activating protein (TRAP)
AU2001238115A1 (en) * 2000-02-10 2001-08-20 Intermune, Inc. Novel amino acid and peptide inhibitors of staphylococcus virulence
WO2001062093A1 (fr) * 2000-02-23 2001-08-30 Kureha Chemical Industry Co., Ltd. Promoteurs de croissance des plantes et procede de promotion de la croissance des plantes
US7824691B2 (en) 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
CA2975568A1 (en) * 2007-10-25 2009-04-30 The Scripps Research Institute Antibody-mediated disruption of quorum sensing in bacteria
EP3072899B1 (en) 2015-03-23 2018-05-02 Eberhard Karls Universität Tübingen Novel anti-infective compound
WO2017136400A1 (en) * 2016-02-02 2017-08-10 Stc. Unm Vlp-based vaccines for targeting staphylococcus aureus secreted virulence factors
AU2018326791B2 (en) * 2017-08-31 2023-12-07 The Regents Of The University Of California Molecular bacteriotherapy to control skin enzymatic activity
KR102195998B1 (ko) * 2019-09-27 2020-12-29 코스맥스 주식회사 스타필로코커스 시뮬란스 st-9 균주 및 그의 피부 상태 개선 용도
KR102286075B1 (ko) * 2019-09-27 2021-08-05 코스맥스 주식회사 스타필로코커스 렌투스 st-2 균주 및 그의 피부 상태 개선 용도
KR102199062B1 (ko) * 2019-09-27 2021-01-06 코스맥스 주식회사 스타필로코커스 자일로서스 st-10 균주 및 그의 피부 상태 개선 용도
CN118931767B (zh) * 2024-07-24 2025-03-25 内蒙古医科大学附属医院(内蒙古自治区心血管研究所) 一株纹带棒状杆菌nmgcs43及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010579A1 (en) * 1994-10-04 1996-04-11 New York University Blocking expression of virulence factors in s. aureus

Also Published As

Publication number Publication date
WO1997044349A1 (en) 1997-11-27
CA2256465A1 (en) 1997-11-27
AU735283B2 (en) 2001-07-05
DE69732709T2 (de) 2006-06-29
JP2000511537A (ja) 2000-09-05
EP0932613B1 (en) 2005-03-09
EP0932613A1 (en) 1999-08-04
EP0932613A4 (en) 2002-01-09
ATE290548T1 (de) 2005-03-15
AU3211797A (en) 1997-12-09
DE69732709D1 (de) 2005-04-14

Similar Documents

Publication Publication Date Title
PT932613E (pt) Expressao de bloqueio de factoes de virulencia em s. aureus
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
PE14199A1 (es) Agonistas de 5-ht1f
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
DE69835536D1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
EP0766674A4 (en) NEW HIV PROTEASE INHIBITORS
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
DE69938935D1 (de) Zyklische conotoxin-peptide
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
PT934065E (pt) Compostos farmaceuticos
DE69729183D1 (de) Als entzündungshemmende mittel nützliche dihydrobenzofurane und verwandte verbindungen
MXPA00007394A (es) Compuestos, composiciones y metodos para tratar o evitar infeccion de neumovirus y enfermedades asociadas.
AU3439799A (en) Immunization against and treatment for infection by (h.pylori)
DK1073436T3 (da) Forbedret fremgangsmåde til udryddelse af helicobacter pylori
BR0111785A (pt) Composições e métodos para tratamento de candidìase
WO2000063386A3 (en) Prevention, diagnosis and treatment of lyme disease
EA200101171A1 (ru) Способ лечения инфекций, вызванных streptococcus pneumoniae
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
NZ505085A (en) Pharmaceutical compositions comprising bipapcitide monocarboxylate and/or bipapcitide dicarboxylate for imaging and treating thrombi
WO2004064784A3 (en) Composition and method for preventing or treating a virus infection
WO1998014567A3 (en) Methods and compositions for inhibiting bacterial growth